...
首页> 外文期刊>Medical science monitor : >Psoriatic onycho-pachydermo-periostitis successfully treated with low-dosemethotrexate.
【24h】

Psoriatic onycho-pachydermo-periostitis successfully treated with low-dosemethotrexate.

机译:低剂量甲氨蝶呤成功治疗了银屑病性灰质-粘液性-皮膜性骨膜炎。

获取原文

摘要

Background: Psoriatic onycho-pachydermo-periostitis (POPP) is a rare manifestationof psoriatic arthritis that is often misdiagnosed as a nail infection. The treatment for POPP has notyet been established. Case Report: We present a case of a 67-year-old man who had no psoriatic skin lesionswith POPP, characterized by psoriatic nail changes, painful swelling of the distal soft tissues on thegreat toes and fingers, and enthesopathies of the involved terminal phalanges. The clinical nail andarthritic changes were improved with methotrexate treatment 4 mg weekly for 6 months. Conclusions: Methotrexatecan be recommended as the first-choice therapeutic agent for patients with POPP.
机译:背景:银屑病性灰指甲-上皮-皮膜性骨膜炎(POPP)是银屑病关节炎的一种罕见表现,通常被误诊为指甲感染。尚未确定POPP的治疗方法。病例报告:本例为一例67岁的男性,无POPP银屑病皮肤损害,其特征为银屑病指甲改变,大脚趾和手指上的远端软组织疼痛肿胀以及所累及的终末趾骨感觉异常。甲氨蝶呤每周4 mg治疗6个月,改善了指甲和关节炎的临床变化。结论:甲氨蝶呤可作为POPP患者的首选治疗药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号